Synthesis and biological activity of oxo-7H-benzo[e]perimidine-4-carboxylic acid derivatives as potent, nonpeptide corticotropin releasing factor (CRF) receptor antagonists

Bioorg Med Chem Lett. 1999 Mar 8;9(5):765-70. doi: 10.1016/s0960-894x(99)00075-x.

Abstract

A novel series of derivatives of oxo-7H-benzo[e]perimidine-4-carboxylic acid (I) potently displaced radioligand binding of 125I-CRF to both CRF1 and CRF2 receptors. The members of this series antagonized CRF-stimulated cAMP formation and CRF-stimulated corticotropin release from rat pituitary in vivo. These are the first nonpeptide antagonists to show activity at both CRF1 and CRF2 receptors.

MeSH terms

  • Adrenocorticotropic Hormone / metabolism
  • Animals
  • Carboxylic Acids / chemical synthesis*
  • Carboxylic Acids / pharmacology
  • Cells, Cultured
  • Cyclic AMP / metabolism
  • Humans
  • Male
  • Pituitary Gland / drug effects*
  • Pituitary Gland / metabolism
  • Quinazolines / chemical synthesis*
  • Quinazolines / pharmacology
  • Rats
  • Receptors, Corticotropin-Releasing Hormone / antagonists & inhibitors*
  • Transfection

Substances

  • Carboxylic Acids
  • Quinazolines
  • Receptors, Corticotropin-Releasing Hormone
  • oxo-7H-benzo(e)perimidine-4-carboxylic acid
  • Adrenocorticotropic Hormone
  • Cyclic AMP